Kenny Walter

The FDA approves Mavyret as an 8-week treatment for all genotypes of HCV with compensated cirrhosis.

In an extensive review of 18 cohort studies, investigators connect dietary patterns with chronic kidney disease incidence rates.

The AGA-approved guidelines call for a variety of different testing to better diagnose IBS-D in adults.

In the updated guidelines, investigators suggest direct-acting antivirals as the preferred treatment for hepatitis C viral infections in chronic kidney disease patients.

Investigators find zolpidem effectively reduces suicidal ideation, particularly for patients suffering from severe insomnia symptoms.

More than 90% of those surveyed report poor sleep quality impacts the next day negatively.

While there is no standard treatment for binge eating disorder, there are ways to help patients.

While there are many options to treat depression, a balance of therapy and medication is often seen as the best method.

There are many factors that make living at home with Alzheimer disease difficult.

Bipolar depression can be difficult to treat and is often misdiagnosed.

Despite being commonly prescribed as an antidepressant, investigators find sertraline more effective at alleviating anxiety symptoms.

While better therapies exist to treat patients with heart failure with reduced ejection fraction, there are several hurdles preventing them from being implemented.

Doctors need to use their best judgement when deciding when to use cardiogenic shock devices for temporary mechanical support.

There are many options to treat heart failure for patients suffering from end stage kidney disease.

Investigators present data during the HFSA meeting on how different types of meals at different time impact the body’s circadian rhythm.

By doubling the recommended weekly dialysis, patients see a number of benefits, including a reduction in blood pressure and improvements in cardiovascular vibration.

In a presentation at the annual HFSA meeting, investigators compare the level of care and ultimate outcomes treating heart failure patients for cardiologists and non-cardiologists.

At the annual HFSA meeting, investigators explain how obstructed sleep apnea and central sleep apnea drive cardiovascular disease.

Lab tests confirm low levels of NDMA in the popular heart burn medication, sparking a probe in the US and Europe.

A pair of new mesh products will optimize hernia surgery, while reinforcing soft tissue with twice the strength.

The aim of the “Alzheimer’s Disease Exposome” will be to identify new interactions of risk genes for future studies.

The FDA-approved drug targets IBS-C patients by increasing bowel movements, while lowering abdominal pain.

Through clinical trials, investigators find that SGLT2 inhibitors are not only safe, but have several cardiovascular benefits.

By allocating 1% of their day to exercise, patients can turn an unhealthy lifestyle into a healthy lifestyle.

Approximately 700,000 adults in the US as of 2016 are suffering from end-stage kidney disease, with transplantation viewed as the preferred treatment.

After success in multiple clinical trials, officials tout esketamine as a treatment for both major depressive disorder with active suicidal ideation and treatment resistant depression.

Investigators report positive results using esketamine spray to treat patients with major depressive disorder.

In a retrospective study using the data of 20,741 patients, investigators discover the primary cause of emergency department visits for geriatric patients is head trauma.

Investigators submit recommendations for physicians for Parkinson disease reflecting recent advancements, including a new section on palliative care.

Investigators find that sofosbuvir is less effective on some HCV infections because of certain amino acid substitutions.